Alzheimer’s Association Awards 5 Grants to Early-Phase Research Projects

Alzheimer’s Association Awards 5 Grants to Early-Phase Research Projects
alzheimers-association-logo1 One of the biggest challenges that research and development in the field of Alzheimer's Disease faces is not the discovery of new treatment candidates, but the lack of funding to advance these discoveries into human testing. In addition, very few funding sources address early-phase clinical drug trials and, as a result, too many promising projects are stalled and lose momentum. Some of the most innovative ideas are even abandoned. In line with its mission to aid early-phase research advancement and completion, the Alzheimer's Association is announcing new grants to fund five early-phase clinical trials to help eliminate this gap in the research process. These grants are care of the Alzheimer's Association's "Part the Cloud Translational Research for Alzheimer's Disease" initiative that supports early-phase research's transition into exploratory research studies, and Phase I clinical trials in humans. These new awards amount to a total of $4 million, making the initiative's total released funding $6 million since its founding. Maria Carrillo, Alzheimer's Association's Chief Science Officer, said in a press
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *